Michele Bronson

About Michele Bronson

Results-oriented C-level executive with 20+ years at start-up to medium-sized biotechnology companies, contributing to the approval of 8 products. I have a proven track record in building stage-appropriate organizations, improving corporate infrastructure, accurate budget planning and management, and effective project and alliance management. My contributions span both strategic and operational domains. I’m particularly passionate about fostering excellence within teams—mentoring, coaching, and creating growth opportunities for employees at all levels.I bring broad expertise in drug development, including both small molecules and biologics, across all stages (pre-IND through post-licensure) and disciplines (clinical, nonclinical, manufacturing), and in diverse therapeutic areas (immunology, oncology, neurology, respiratory, sepsis, rheumatology). Central to many of my successes has been the ability to build productive relationships with development partners as well as regulatory authorities—resulting in effective resolution of complex issues, successful inspections, and accelerated regulatory approvals.

Experience

1. Board Observer

   Ten63 Therapeutics

   Jan 2020 — Present

   Working with company leadership, providing strategic development expertise and representing IndieBio investment interests.

Education

• UT Southwestern Medical Center

  PhD, Molecular Immunology

Skills

• Oncology
• Quality System
• Regulatory Affairs
• Project Management
• Gmp